Respiratory syncytial virus (RSV) causes symptoms like sneezing and coughing. In children, especially those under 2 years old, RSV can also cause bronchiolitis, which is inflammation of the small ...

Respiratory syncytial virus (RSV) is a virus that generally causes mild, common cold-like symptoms. While RSV can be serious in young children and older adults, it’s usually mild in teens, lasting 7 ...

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for ...

For the first time this fall, families will be offered season-long protection for infants and some children against respiratory syncytial virus (RSV). The US Food and Drug Administration (FDA) in July ...

Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections that often presents as a simple cold in most adults. However, for some individuals, it can become a more ...

The CDC issued an alert on who should be prioritized for the drug. The U.S. Centers for Disease Control and Prevention said in a health alert issued Monday that infants younger than 6 months old, as ...

New data reveals that Montana is among the top states in the nation for protecting infants from Respiratory Syncytial Virus ...

Each year, respiratory syncytial virus hospitalizes 58,000 to 80,000 children under age 5 in the U.S. The Food and Drug Administration recently approved an antibody injection for babies to protect ...

Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and ...

If your patient is pregnant or older than 60 years and due for a respiratory syncytial virus (RSV) shot, now’s the time to act. A major new review highlighted the vaccine’s impact and safety, ...